日本子宫内膜癌患者特征与治疗模式的真实世界数据库分析

数据集获取（Figshare）

• 源站标题：Real-world database analysis of the characteristics and treatment patterns of patients with endometrial cancer in Japan
• DOI：10.6084/m9.figshare.14355983.v2
• 发布日期：2021-05-14
• 文件数：6 个
• 文件总体积：618.66 KB
• 源站页面：https://tandf.figshare.com/articles/dataset/Real-world_database_analysis_of_the_characteristics_and_treatment_patterns_of_patients_with_endometrial_cancer_in_Japan/14355983

命令行下载

curl -L -o "icmo_a_1903847_sm5007.docx" "https://ndownloader.figshare.com/files/28007797"
curl -L -o "icmo_a_1903847_sm3149.docx" "https://ndownloader.figshare.com/files/27400469"
curl -L -o "icmo_a_1903847_sm3148.docx" "https://ndownloader.figshare.com/files/27400472"
curl -L -o "icmo_a_1903847_sm3147.doc" "https://ndownloader.figshare.com/files/27400475"
curl -L -o "icmo_a_1903847_sm3146.docx" "https://ndownloader.figshare.com/files/27400478"
curl -L -o "icmo_a_1903847_sm3145.tif" "https://ndownloader.figshare.com/files/27400481"

文件清单

• icmo_a_1903847_sm5007.docx（11.78 KB）
• icmo_a_1903847_sm3149.docx（21.95 KB）
• icmo_a_1903847_sm3148.docx（25.13 KB）
• icmo_a_1903847_sm3147.doc（35.33 KB）
• icmo_a_1903847_sm3146.docx（22.30 KB）
• icmo_a_1903847_sm3145.tif（502.17 KB）

文件总体积 618.66 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

The aim was to identify the characteristics and treatment patterns of early and advanced stage endometrial cancer patients using real-world data.
Patients’ data extracted from a Japanese health insurance claims database were analyzed.
Of the 12,449 endometrial cancer patients, 74.4% were in stage I, 5.1% in stage II, 12.0% in stage III, and 8.4% in stage IV. Their median age was 60.5 years, higher in advanced stages (III/IV) than in early stages (I/II). Overall, 11,055 patients (88.8%) underwent surgery, and 4977 patients (40.0%) received post-surgery treatment, including chemotherapy (4441: 35.7%), chemoradiation therapy (379: 3.0%), and radiation therapy (157 patients: 1.3%); 1394 patients (11.2%) were not treated by surgery, and 742 patients (6.0%) received other treatment, with chemotherapy (548: 4.4%), radiation therapy (105: 0.8%), and chemoradiation therapy (89: 0.7%). The rate of patients undergoing surgery decreased, and that receiving chemotherapy increased significantly as cancer stage progressed. Paclitaxel/carboplatin was the most frequent first-line regimen (85.4% of patients), whereas various combination and monotherapy regimens were used as second- and third-line regimens. The most frequent second-line monotherapy was paclitaxel. The rate of monotherapy increased as the treatment line progressed (first-line 3.5%, second-line 22.0%, and third-line 36.4%).
The characteristics and treatment patterns of endometrial cancer patients differed between early and advanced stages, as did the chemotherapy regimens among first-, second-, and third-lines. Since various regimens were used for second- and third-line chemotherapies, development of appropriate second- and third-line chemotherapy regimens is warranted. A real-world analysis of cancer patients using a nationwide claims database may be a valuable approach to identifying unmet medical needs.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.6084/m9.figshare.14355983.v2（source: https://tandf.figshare.com/articles/dataset/Real-world_database_analysis_of_the_characteristics_and_treatment_patterns_of_patients_with_endometrial_cancer_in_Japan/14355983）。